Stockholders’ Equity - Schedule of Warrants Outstanding (Details) - $ / shares |
12 Months Ended | ||||
|---|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Schedule of Warrants Outstanding [Line Items] | |||||
| Shares, Outstanding, Ending | 7,152 | ||||
| Weighted Average Exercise Price, Ending | $ 15.72 | ||||
| Shares, Granted | 152,739 | ||||
| Weighted Average Exercise Price, Granted | $ 7.48 | ||||
| Warrant [Member] | |||||
| Schedule of Warrants Outstanding [Line Items] | |||||
| Shares, Outstanding, Ending | 2 | 477,540 | 23,184 | ||
| Weighted Average Exercise Price, Ending | [1] | $ 357,140 | $ 5.1 | $ 55.8 | |
| Weighted Average Remaining Contractual Term (Years), Ending | 3 years 1 month 6 days | 1 year 3 months 18 days | 2 years 3 months 18 days | ||
| Shares, Granted | 363,732 | 13,034 | |||
| Weighted Average Exercise Price, Granted | [1] | $ 6.7 | $ 90 | ||
| Weighted Average Remaining Contractual Term (Years), Granted | 1 year 9 months 18 days | 2 years 7 months 6 days | |||
| Shares, Adjustment | [1] | 389,947 | 19,961 | ||
| Weighted Average Exercise Price, Adjustment | [1] | $ (4.5) | $ (55.8) | ||
| Shares, Exercised | (299,323) | (9,813) | |||
| Weighted Average Exercise Price, Exercised | [1] | $ 5.6 | $ 38.6 | ||
| |||||